trial · primary record
Pirtobrutinib
Chronic Lymphocytic Leukemia
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2033-06-01 |
| Primary endpoint | Safety and adverse events |
| Registry ID | NCT06967610 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:56:15.260Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06967610
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Pirtobrutinib · approval
- Pirtobrutinib · compound